arrow
L

Ling Shi

university of massachusetts system
H指数:32
被引数:3,328

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib

纳拉蒂布或伊马替尼治疗新诊断的费城染色体阳性急性淋巴细胞白血病患者中,临床反应和治疗耐受性对健康相关生活质量的影响

2025-10-100
OA
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trial

nivolumab联合relatlimab与nivolumab单药治疗先前未经治疗的不可切除或转移性黑色素瘤患者的健康相关生活质量: RELATIVITY-047试验

2023-07-0111
PRE